Soluble CD4 and dextran sulfate mediate release of gp120 from HIV-1: implications for clinical trials.
Bugelski
P J
PJ
Ellens
H
H
Hart
T K
TK
Kirsh
R L
RL
D000163:Acquired Immunodeficiency Syndrome / Q000628:therapy; D015704:CD4 Antigens / Q000502:physiology* / Q000627:therapeutic use; D002460:Cell Line; D002986:Clinical Trials as Topic; D016264:Dextran Sulfate / Q000494:pharmacology* / Q000627:therapeutic use; D015699:HIV Envelope Protein gp120 / Q000187:drug effects* / Q000276:immunology; D006801:Humans; D012995:Solubility
D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D016264:Dextran Sulfate